Employee Benefit Plans (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Nonvested Share Activity

The Company’s RSU, RSA, and PSA activities and related information as of and for the six months ended June 30, 2024 were as follows (in millions, except per share amounts and years):

	Outstanding RSUs, RSAs, and PSAs
	Number of Shares	Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value
Balance as of December 31, 2023	20.2	$	28.10
Granted(*)	3.4	35.00
Vested	(3.9)	26.44
Cancelled	(1.5)	27.28
Balance as of June 30, 2024	18.2	$	29.83	1.0	$	662.3

________________________________

(*)    Includes 1.6 million service-based and 1.8 million performance-based awards. The number of shares subject to performance-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.

Schedule of Employee Stock Purchases through ESPP

The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):

	Six Months Ended June 30,
	2024		2023
Shares purchased	1.3		1.3
Average exercise price per share	$	23.81	$	23.44

Schedule of Employee Service Share-Based Compensation, Allocation of Recognized Period Costs

Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and ESPP purchase rights was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Cost of revenues - Product	$	1.4	$	1.7	$	3.2	$	3.4
Cost of revenues - Service	4.9		4.7		10.4		9.4
Research and development	26.4		26.1		64.9		51.8
Sales and marketing	18.7		19.4		42.8		38.0
General and administrative	9.9		10.1		19.9		20.3
Total	$	61.3	$	62.0	$	141.2	$	122.9

Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award

The following table summarizes share-based compensation expense by award type (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Stock options	$	0.3	$	0.6	$	0.6	$	1.4
RSUs, RSAs, and PSAs	56.2		54.9		129.1		107.9
ESPP purchase rights	4.8		6.5		11.5		13.6
Total	$	61.3	$	62.0	$	141.2	$	122.9